Literature DB >> 23079703

Overexpression of Six1 leads to retardation of myogenic differentiation in C2C12 myoblasts.

Zhixue Li1, Daming Deng, Huocong Huang, Liang Tian, Zirong Chen, Youran Zou, Guorong Jin, Juan Wang, Qingjiong Zhang, Lizi Wu, Huangxuan Shen.   

Abstract

The Six1 homeoprotein belongs to the Six (sine oculis) transcription factor family, the members of which are known to act as master regulators of development. Six1 is essential for promoting myogenesis during mammalian somitogenesis. Previous studies have shown that Six1 participates in later steps of myogenic differentiation by enhancing early activation of myogenin via binding to the Mef3 site of the myogenin promoter. In the present study, however, we show that overexpression of Six1 via retroviral infection suppresses the expression of myogenin and myosin in C2C12 myoblasts, consequently retarding myogenic differentiation without affecting cell proliferation or expression of Mef2 and Mef3. These findings further demonstrate the functional role of Six1 in myogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079703     DOI: 10.1007/s11033-012-2052-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  36 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Six and Eya expression during human somitogenesis and MyoD gene family activation.

Authors:  Françoise Fougerousse; Muriel Durand; Soledad Lopez; Laurence Suel; Josiane Demignon; Charles Thornton; Hidenori Ozaki; Kyoshi Kawakami; Patrick Barbet; Jacques S Beckmann; Pascal Maire
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 3.  Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos.

Authors:  Mary Elizabeth Pownall; Marcus K Gustafsson; Charles P Emerson
Journal:  Annu Rev Cell Dev Biol       Date:  2002-04-02       Impact factor: 13.827

Review 4.  The genetics of vertebrate myogenesis.

Authors:  Robert J Bryson-Richardson; Peter D Currie
Journal:  Nat Rev Genet       Date:  2008-08       Impact factor: 53.242

Review 5.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.

Authors:  B L Black; E N Olson
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

6.  Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.

Authors:  A G Ridgeway; S Wilton; I S Skerjanc
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

7.  Six class homeobox genes in drosophila belong to three distinct families and are involved in head development.

Authors:  H C Seo; J Curtiss; M Mlodzik; A Fjose
Journal:  Mech Dev       Date:  1999-05       Impact factor: 1.882

8.  A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis.

Authors:  Chaoshe Guo; Ye Sun; Bin Zhou; Rosalyn M Adam; XiaoKun Li; William T Pu; Bernice E Morrow; Anne Moon; Xue Li
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

9.  Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer.

Authors:  Charis L Himeda; Jeffrey A Ranish; John C Angello; Pascal Maire; Ruedi Aebersold; Stephen D Hauschka
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.

Authors:  S M Farabaugh; D S Micalizzi; P Jedlicka; R Zhao; H L Ford
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

View more
  1 in total

1.  SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis.

Authors:  Modjtaba Emadi-Baygi; Parvaneh Nikpour; Elaheh Emadi-Andani
Journal:  Adv Biomed Res       Date:  2015-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.